Hvilke foranstaltninger vil Kommissionen træffe over for medicinalvirksomheder, der forsøger at begrænse parallelhandel i medicinalsektoren?
What action will the Commission take against pharmaceuticals companies that attempt to curtail parallel trading in the medicines sector?